Treatment

ASP2390 clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE1
A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites
This study is looking into a new treatment called ASP2390 for people allergic to house dust mites. It aims to check if the treatment is safe, how well people tolerate it, and if it helps the body's immune system respond to dust mites.
For: Allergic to House Dust Mites
Germany